Company intelligence / Profile preview

PharmaMatrix Holdings

Yardley, Pennsylvania, USA

Ownership: Private
Development stage: Other

Overview

PharmaMatrix is a pharmaceutical consulting and contract research organization (CRO) that provides strategic and technical expertise in drug development, with a focus on clinical pharmacology and regulatory affairs. The company specializes in pharmacokinetics (PK), pharmacodynamics (PD), and the design and management of Phase 1 and Phase 2 clinical trials. PharmaMatrix assists biotechnology and pharmaceutical companies in navigating the FDA's Investigational New Drug (IND) and New Drug Application (NDA) processes, offering services such as protocol development, data analysis, and quality assurance auditing. The firm is particularly recognized for its expertise in bioequivalence studies and clinical pharmacology strategy.

Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on PharmaMatrix Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaMatrix Holdings.

Explore the full profile